Fund shareholders of Bridgebio Pharma Inc
ISIN US10806X1028 · United States · LEI 54930028YG89VTY2J114
- Fund shareholders
- 455
- Of which ETFs
- 81 374 other funds
- Value held
- 5B $ 330.7M SEK · 167.2K €
- Share of capital
- 35.2 % of 195.5M shares on Aug 3, 2026
455 funds hold this company. This table lists the 454 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| BlackRock Advantage SMID Cap V.I. Fund BlackRock Variable Series Funds, Inc. | 1,353 | 100.5K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 1,325 | 98.4K $ | 0.51 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. | 1,322 | 98.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 1,310 | 87.1K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 1,299 | 92.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 1,280 | 85.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| GuideMark Small/Mid Cap Core Fund GPS Funds I | 1,160 | 86.1K $ | 0.09 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. | 1,123 | 83.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 1,107 | 73.6K $ | 0.07 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Strategic Allocation: Moderate Fund American Century Strategic Asset Allocations Inc | 1,105 | 78.6K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Franklin Alternative Strategies Fund Franklin Alternative Strategies Funds | 1,070 | 71.1K $ | 0.01 % | 0.00 % | as of Feb 27, 2026 ↗ |
| Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 968 | 71.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Quality ETF American Century ETF Trust | 966 | 64.2K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 949 | 63.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| American Century Small Cap Growth Insights ETF American Century ETF Trust | 904 | 60.1K $ | 0.67 % | 0.00 % | as of Feb 28, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 894 | 66.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 778 | 57.8K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 778 | 57.8K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 744 | 55.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 694 | 51.5K $ | 0.41 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA U.S. Core Market Fund SA FUNDS INVESTMENT TRUST | 679 | 50.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 650 | 43.2K $ | 0.16 % | 0.00 % | as of Feb 28, 2026 ↗ |
| MFS Blended Research Small Cap Equity Portfolio MFS VARIABLE INSURANCE TRUST III | 564 | 41.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 531 | 39.4K $ | 0.26 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Innovative Growth Factor ETF RBB Fund, Inc. | 518 | 34.4K $ | 0.57 % | 0.00 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 441 | 32.7K $ | 0.22 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 401 | 29.8K $ | 0.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Virtus AlphaSimplex Global Alternatives Fund Virtus Alternative Solutions Trust | 364 | 27K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Motley Fool Momentum Factor ETF RBB Fund, Inc. | 361 | 24K $ | 0.50 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 358 | 26.6K $ | 0.21 % | 0.00 % | as of Mar 31, 2026 ↗ |
| THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds | 355 | 25.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Harbor Active Small Cap Growth ETF Harbor ETF Trust | 350 | 24.9K $ | 0.68 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Fidelity Flex Mid Cap Focused Index Fund Fidelity Salem Street Trust | 348 | 24.7K $ | 0.18 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Strategic Allocation: Conservative Fund American Century Strategic Asset Allocations Inc | 347 | 24.7K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 290 | 20.6K $ | 0.26 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 282 | 20.1K $ | 0.02 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Virtus Silvant Small/Mid Growth ETF Virtus ETF Trust II | 280 | 19.9K $ | 0.63 % | 0.00 % | as of Apr 30, 2026 ↗ |
| New Covenant Growth Fund NEW COVENANT FUNDS | 241 | 17.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 214 | 15.9K $ | 0.27 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 200 | 14.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Company Growth Portfolio Wilshire Mutual Funds Inc | 190 | 14.1K $ | 0.07 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 174 | 11.6K $ | 0.13 % | 0.00 % | as of Feb 28, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 172 | 12.8K $ | 0.56 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JPMorgan Fundamental Data Science Small Core ETF J.P. Morgan Exchange-Traded Fund Trust | 166 | 12.3K $ | 0.17 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 164 | 12.2K $ | 0.40 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 163 | 10.8K $ | 0.04 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Sector Rotation Fund Meeder Funds | 129 | 9.6K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Lazard Enhanced Opportunities Portfolio LAZARD FUNDS INC | 129 | 9.6K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 126 | 9K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Founders 100 ETF Founder Funds Trust | 102 | 7.6K $ | 0.34 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 50 | 3.3K $ | 0.30 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 41 | 3K $ | 0.11 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 6 | 398.9 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| GVC GAESCO ZEBRA US SMALL CAPS LOW POPULARITY, FI GVC GAESCO GESTIÓN, SGIIC, S.A. | 167.2K € | 1.28 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 5.75 % | as of Mar 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 4.75 % | as of Feb 28, 2026 ↗ |
| Franklin Genomic Advancements ETF Franklin Templeton ETF Trust | 4.22 % | as of Mar 31, 2026 ↗ |
| F/m Emerald Life Sciences Innovation ETF RBB Fund, Inc. | 2.56 % | as of Feb 28, 2026 ↗ |
| SIMT Small Cap Growth Fund SEI INSTITUTIONAL MANAGED TRUST | 2.43 % | as of Mar 31, 2026 ↗ |
| Victory RS Select Growth Fund Victory Portfolios | 2.27 % | as of Mar 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 2.23 % | as of Feb 28, 2026 ↗ |
| Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND | 2.22 % | as of Mar 31, 2026 ↗ |
| Developing Growth Portfolio LORD ABBETT SERIES FUND INC | 2.21 % | as of Mar 31, 2026 ↗ |
| NICHOLAS PARTNERS SMALL CAP GROWTH FUND ADVISORS' INNER CIRCLE III | 2.15 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 448 | +35 | 68,423,703 | +4.7 % |
| 2026Q1 | 413 | +58 | 65,336,428 | +9.0 % |
| 2025Q4 | 355 | +35 | 59,967,793 | +4.5 % |
| 2025Q3 | 320 | +41 | 57,383,094 | +13.0 % |
| 2025Q2 | 279 | +44 | 50,770,124 | +7.7 % |
| 2025Q1 | 235 | -11 | 47,152,884 | +8.5 % |
| 2024Q4 | 246 | -24 | 43,448,131 | +2.9 % |
| 2024Q3 | 270 | -6 | 42,238,206 | +3.2 % |
| 2024Q2 | 276 | +15 | 40,932,145 | +1.2 % |
| 2024Q1 | 261 | +33 | 40,458,314 | +18.0 % |
| 2023Q4 | 228 | 34,283,131 |
Institutional managers
449 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 14,207,757 | 1.1B $ | as of Mar 31, 2026 |
| Kohlberg Kravis Roberts & Co. L.P. | 13,260,971 | 984.8M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 13,179,013 | 978.6M $ | as of Mar 31, 2026 |
| VIKING GLOBAL INVESTORS LP | 11,842,434 | 879.4M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 9,365,463 | 695.5M $ | as of Mar 31, 2026 |
| Aisling Capital Management LP | 5,089,611 | 378M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,934,320 | 366.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,918,030 | 371.9M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 4,592,814 | 341.1M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,801,655 | 282.3K $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 3,448,139 | 256.1M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 3,173,940 | 235.7M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,120,631 | 231.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 2,545,486 | 189M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 2,519,306 | 187.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,483,953 | 184.5M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,438,925 | 181.1M $ | as of Mar 31, 2026 |
| FMR LLC | 2,343,754 | 174M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,026,821 | 150.5M $ | as of Mar 31, 2026 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 1,977,080 | 146.8M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,976,094 | 146.7M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 1,908,907 | 146M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,897,716 | 140.9M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,877,359 | 139.4M $ | as of Mar 31, 2026 |
| SC US (TTGP), LTD. | 1,860,364 | 138.2M $ | as of Mar 31, 2026 |
Declared shareholders of Bridgebio Pharma Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.80 % | 13,179,013 | as of Mar 31, 2026 · SCHEDULE 13G |
| VIKING GLOBAL INVESTORS LP and 6 others | 6.10 % | 11,842,434 | as of Mar 31, 2026 · SCHEDULE 13D |
| Farallon Capital Partners, L.P. and 27 others | 5.20 % | 10,226,063 | as of May 22, 2026 · SCHEDULE 13G |
Funds holding the debt of Bridgebio Pharma Inc
56 funds declare 89 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Bridgebio Pharma Inc". https://titelia.com/en/stocks/bridgebio-pharma-inc-US10806X1028